Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3591_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
89 Мб
Скачать
454
ab
cd
ab
Fig. 36.8 USG-guided FNAB of laryngeal mass. For a 52-year-old patient with a mass in the glottis and supraglottis, a biopsy attempted twice via direct laryngoscopy was negative. On USG, a heterogenous mass (asterisk in a) is seen in the glottis and supraglottis with erosion of thyroid lamina and resultant extralaryngeal extension (asterisk in b). Extralaryngeal extension of the lesion was targeted under USG.A 22G needle was inserted under USG guidance (arrow in c) and a nal needle aspiration biopsy was done. Biopsy revealed squamous cell carcinoma
S. Sharma et al.
Fig. 36.9 USG-guided FNAC of thyroid lesion. Post-left hemithyroidectomy case of follicular variant of papillary carcinoma of the thyroid. An isoechoic solid taller than a wider lesion (asterisk in a) with smooth margins is seen in the right lobe of the thyroid gland with no calcication. On color Doppler (b), the lesion shows vascularity within the lesion. Image c shows needle insertion (arrow in c) under USG guidance followed by FNAC from the lesion
c
36 Nonvascular Inter ventions ofHead andNeck
455
To conclude, ultrasound is the primary modality used to guide sampling of the supercial head and neck lesions with minimal patient risk and excellent tissue sampling.
36.5 Ultrasound-Guided Percutaneous
Drainage ofHead andNeck Abscess
Deep head and neck infection with abscess formation is a poten­tial complication following upper respiratory tract and odonto­genic infections in children and adults. Due to anatomic localization of vital structures in head and neck, emergent treat­ment of abscess is imperative. Antibiotics alone or in combina­tion with surgical drainage are routinely used for management of abscess. Surgical drainage is usually done under general anesthe­sia and is associated with signicant disadvantages like cosmeti­cally unpleasant scars and potential risk of neuro-vascular injury.
Ultrasound-guided drainage of head and neck abscess is a minimally invasive, cost-effective technique and is gaining popularity for management. It is very effective in draining deep neck infections without recurrence and with minimal to nil risk to neurovascular structures of head and neck. Needle aspiration with a wide bore needle (14/16/18G) can be done in small volume abscess or a pig-tail drainage can be done if the abscess is large [16, 31].
treatment is covered in detail in chapter on vascular interven­tions in head and neck.
36.5.2 Percutaneous Sclerotherapy ofHead andNeck Low-Flow Vascular Malformations andCystic Lesions
Image-guided sclerotherapy is a less invasive and relatively safe percutaneous technique for the treatment of low-ow vascular malformations and cystic lesions of the head and neck. This technique is particularly useful for poorly dened transpatial vascular malformations close to vital structures where complete surgical resection is technically challenging and the risk of injury to adjacent structures is high. Sclerotherapy in cystic lesions like thyroglossal duct cyst, branchial cleft cyst, ranulas, and benign thyroid cysts is less frequently used and surgery remains the rst line of treat­ment. Epithelial-lined cystic lesions are pathologically dis­tinct from endothelial-lined vascular malformations and reports of the use of sclerotherapy for treatment are limited and need further validation.
36.6 Radiofrequency Ablation ofHead andNeck Tumors
36.5.1 Interventional Radiology inVascular Malformations
Interventional radiology plays a key role in the management of vascular malformations of head and neck. Detailed knowledge of head and neck anatomy, potential site involved, and associ­ated specic complications is required before treating any vas­cular malformation. Broadly the malformations are classied as being low ow or high ow depending on the absence or presence of arterial feeders. Understanding ISSVA classica­tion and its management implications is imperative before treating any vascular malformation. The classication is cov­ered in the chapter on vascular malformations.
Pre-treatment dynamic MRI is essential to understand the nature of vascular malformation and vascular feeders if any. Low-ow malformations are treated with percutaneous sclerotherapy while the high-ow ones are treated with endovascular embolization. High ow malformations and its
Malignant tumors of the head and neck region account for a significant number of cases in the elderly popula­tion. Advanced head and neck malignant tumors are noto­rious for recurrence and have low 5-year survival rates. Despite the best palliative care and treatment, patients suffer from disease and treatment morbidity with low quality of life. Treatment options for advanced or recur­rent head and neck tumors are often challenging owing to the proximity of multiple adjacent vital structures in the head and neck.
Radiofrequency ablation is a promising alternative for the palliative treatment of advanced head and neck tumors with minimal complications. The procedure is performed under GA and the patient can be discharged the next day. Placement of the RFA probe into the tumor is guided by USG or CT.Immediate response in pain is noted following RFA with a reduction in the bulk of tumor. RFA has proven effective inlocal control of disease and thus improving quality of life
456
S. Sharma et al.
in end-stage head and neck malignancies where standard curative treatment is not an option [10, 16, 32].

36.7 Conclusion

Image-guided sampling is an established technique in the head and neck region with USG being preferred for super­cial locations like thyroid, parotid, and supercial cervi­cal lymph nodes whereas CT guidance is used for deep-seated lesions. USG-guided drainage of deep-seated head and neck abscesses is a minimally invasive, cost­effective technique, and is gaining popularity for management.
Percutaneous sclerotherapy under USG guidance is used
widely for low-ow vascular malformations.
RFA in advanced and recurrent head and neck malignan­cies has proven effective in local control of disease and improving quality of life where standard curative treatment has failed.

References

1. Gupta S, Henningsen JA, Wallace MJ, Madoff DC, Morello FA Jr, Ahrar K, Murthy R, Hicks ME. Percutaneous biopsy of head and neck lesions with CT guidance: various approaches and rel­evant anatomic and technical considerations. Radiographics. 2007;27(2):371–90.
2. Abemayor E, Ljung BM, Ward PH, Larsson S, Hanafee W.CT-directed ne needle aspiration biopsies of masses in the head and neck. Laryngoscope. 1985;95:1382–6.
3. Abrahams JJ.Mandibular sigmoid notch: a window for CT-guided biopsies of lesions in the peripharyngeal and skull base regions. Radiology. 1998;208:695–9.
4. DelGaudio JM, Dillard DG, Albritton FD, Hud-gins P, Wallace VC, Lewis MM. Computed tomography guided needle biopsy of head and neck lesions. Arch Otolaryngol Head Neck Surg. 2000;126:366–70.
5. Fried MP, Hsu L, Jolesz FA. Interactive magnetic resonance imaging- guided biopsy in the head and neck: initial patient experi­ence. Laryngoscope. 1998;108:488–93.
6. Gatenby RA, Mulhern CB Jr, Strawitz J.CT-guided percutaneous biopsies of head and neck masses. Radiology. 1983;146:717–9.
7. Merkle EM, Lewin JS, Aschoff AJ, etal. Percutaneous magnetic resonance image-guided biopsy and aspiration in the head and neck. Laryngoscope. 2000;110:382–5.
8. Sack MJ, Weber RS, Weinstein GS, Chalian AA, Nisenbaum HL, Yousem DM. Image-guided ne-needle aspiration of the head
and neck: 5 years-experience. Arch Otolaryngol Head Neck Surg. 1998;124:1155–61.
9. Sherman PM, Yousem DM, Loevner LA.CT-guided aspirations in the head and neck: assessment of the rst 216 cases. AJNR Am J Neuroradiol. 2004;25:1603–7.
10. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities—part II. J Vasc Interv Radiol. 2001;12(10):1021–135. [-1148]
11. Kraft M, Gurtler N, Schmuziger N, etal. Ultrasound-guided core­needle biopsy in the diagnosis of head and neck lesions. J Laryngol Otol. 2007;121(9):895–6.
12. Curtin HD, Brogle N, Caruso P.Imaging-guided biopsy. Atlas Oral Maxillofac Surg Clin North Am. 2005;13(1):51–62.
13. Loevner LA.Image-guided procedures of the head and neck: the radiologist’s arsenal. Otolaryngol Clin N Am. 2008;41(1):231–50.
14. Gazelle GS, Haaga JR.Biopsy needle characteristics. Cardiovasc Intervent Radiol. 1991;14:12–6.
15. Franseen CC.Aspiration biopsy with a description of a new type of needle. N Engl J Med. 1991;224:1054–8.
16. Som PM, Curtin HD. Head and Neck Imaging. 5th ed. Mosby Elsevier; 2011.
17. Akins EW, Hawkins IF Jr, Mladinich C, Tupler R, Siragusa RJ, Pry R.The blunt needle: a new percutaneous access device. AJR Am J Roentgenol. 1989;152:181–2.
18. Mukherji SK, Turetsky D, Tart RP, Mancuso AA.A technique for core biopsies of head and neck masses. AJNR Am J Neuroradiol. 1994;15:518–20.
19. Esposito MB, Arrington JA, Murtagh FR, Ridley MB, Endicott JN, Silbiger ML.Anterior approach for CT-guided biopsy of skull base and parapharyngeal space lesions. J Comput Assist Tomogr. 1996;20:739–41.
20. Tu AS, Geyer CA, Mancall AC, Baker RA. The buccal space: a doorway for percutaneous CT-guided biopsy of the parapharyngeal region. AJNR Am J Neuroradiol. 1998;19:728–31.
21. Dresel SH, Mackey JK, Lufkin RB, et al. Meckel cave lesions: percutaneous ne-needle-aspiration biopsy cytology. Radiology. 1991;179:579–82.
22. Menezes AH, VanGilder JC. Transoral-transpharyngeal approach to the anterior craniocervical junction: ten-year experience with 72 patients. J Neurosurg. 1988;69:895–903.
23. Patil AA. Transoral stereotactic biopsy of the second cervical vertebral body: case report with technical note. Neurosurgery. 1989;25:999–1001; discussion 1001–1002.
24. Kang M, Gupta S, Khandelwal N, Shankar S, Gulati M, Suri S.CT-guided ne-needle aspiration biopsy of spinal lesions. Acta Radiol. 1999;40:474–8.
25. Kattapuram SV, Rosenthal DI. Percutaneous biopsy of the cervical spine using CT guidance. AJR Am J Roentgenol. 1987;149:539–41.
26. Ottolenghi CE, Schajowicz F, Deschant FA.Aspiration biopsy of the cervical spine: technique and results in thirty-four cases. J Bone Joint Surg Am. 1964;46:715–33.
27. Tampieri D, Weill A, Melanson D, Ethier R.Percutaneous aspi­ration biopsy in cervical spine lytic lesions: indications and tech­nique. Neuroradiology. 1991;33:43–7.
36 Nonvascular Inter ventions ofHead andNeck
457
28. Screaton NJ, Berman LH, Grant JW.US-guided core-needle biopsy of the thyroid gland. Radiology. 2003;226:827–32.
29. Screaton NJ, Berman LH, Grant JW.Head and neck lymphadenop­athy: evaluation with US guided cutting-needle biopsy. Radiology. 2002;224:75–81.
30. Ridder GJ, Technau-Ihling K, Boedeker CC. Ultrasound-guided cutting needle biopsy in the diagnosis of head and neck masses. Laryngoscope. 2005;115:376–7.
31. Biron VL, Kurien G, Dziegielewski P, Barber B, Seikaly H.Surgical vs ultrasound-guided drainage of deep neck space abscesses: a randomized controlled trial: surgical vs ultrasound drainage. J Otolaryngol Head Neck Surg. 2013;42(1):18.
32. Owen RP, Silver CE, Ravikumar TS, Brook A, Bello J, Breining D.Techniques for radiofrequency ablation of head and neck tumors. Arch Otolaryngol Head Neck Surg. 2004;130(1):52–6.

Nonvascular Thoracic Interventions

AbhishekJayant, AshuSeithBhalla, PriyankaNaranje, andIshanGupta
37
Key Messages
1. Image-guided thoracic non-vascular procedures include predominantly transthoracic FNACs/Biopsies, percuta­neous drainage procedures and lung tumour ablation.
2. Thoracocentesis can be performed for diagnostic pur­poses or for therapeutic purposes for both air and uid removal using small bore needles and pigtail drainage catheters.
3. USG and CT guidance are helpful in safe and accurate access and catheter placements for drainage.
4. The primary indication for intrapleural brinolytic ther­apy is empyema that is unlikely to completely resolve just with tube thoracostomy due to loculations and brin deposition, resulting in non-expansion of the underlying lung.
5. Various agents that can be used for intrapleural brino­lysis are streptokinase, urokinase, recombinant tissue plasminogen activator (rtPA) and DNase.
6. Indwelling pleural catheter (IPC) is considered in patients in whom the pleural effusions are expected to reaccumulate in a short time such as in malignant effu­sions. The subcutaneous tunnel helps to secure the cath­eter with less risk of secondary infection.
7. CT-guided drainage using Seldinger technique for cath­eter placement can be done in cases of mediastinal col­lections and lung abscesses for patients not responding to medical therapy.
8. According to the Society of Interventional Radiology (SIR) consensus guidelines for the periprocedural man­agement of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions,
percutaneous lung biopsy is classied as a high bleeding risk procedure. For such procedures, INR and platelets should be 1.5 and ≥ 50,000/μL, respectively. Clopidogrel should be withheld 5days prior to the pro­cedure, and aspirin should be withheld 3–5days before the procedure.
9. For CT-guided lung lesion biopsy, the access site should be chosen in such a way that it traverses the least amount of aerated lung and avoids emphysematous lung, bullae, ssure and major bronchi and vessels.
10. Pneumothorax is the most common complication of per­cutaneous lung biopsy. Most of them are small with only a few requiring chest tube drainages. Other complica­tions include pulmonary haemorrhage, air embolism and tumour seeding.
11. CT-guided radiofrequency ablation (RFA) is a safe and effective treatment option for lung cancer, especially lung metastasis up to 2cm in patients who are not surgi­cally t.

37.1 Introduction

Non-vascular thoracic interventions are frequently per­formed in IR procedures. The various non-vascular thoracic interventions include various diagnostic and therapeutic pro­cedures such as pleural uid tapping, biopsy, drainage, abla­tion, etc. The vascular interventions of the thorax are covered in Chap. 19.

37.2 Thoracic Drainage Procedures

A. Jayant · I. Gupta Fellow Thoracic Radiology, Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences, Delhi, India
A. S. Bhalla ( Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences, Delhi, India
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024 S. H. Chandrashekhara (ed.), Textbook of Interventional Radiology, https://doi.org/10.1007/978-981-97-9601-4_37
*) · P. Naranje
Pleural and mediastinal compartments are potential spaces where uid and/or air can accumulate resulting in impair­ment of respiratory and cardiovascular function. The nature of uid can be transudative, exudative, haemorrhagic or purulent. If uid is purulent in nature it can contribute to sepsis and the age-old principle of “pus anywhere in the
459
460
A. Jayant et al.
body requires drainage” should be followed. Accordingly, image-guided procedures are aimed at establishing the nature of uid by thoracentesis and providing therapeutic drainage by a percutaneous catheter system.
37.2.1 Pre-Procedure Evaluation
Medication Check Including Antiplatelets and Anticoagulation Elective Pleural Procedures
For those with a high risk of thrombosis (e.g., coronary stents), multidisciplinary team discussion may be required. In cases of elective procedures, the following recommenda­tions are followed:
• Warfarin should be stopped 5days before the procedure,
and pre-procedure INR should be 1.5.
• Direct oral anticoagulant medication (DOAC) should be
withheld 24–48 hours before the procedure and be
resumed 24 hours after a low-risk procedure and
48–72hours after a high-risk procedure. For patients at
high risk of venous thrombosis, daily prophylactic hepa-
rin should be considered prior to restarting the DOAC.
• Clopidogrel and prasugrel should be withheld 5 days
prior to the elective procedure. For Ticagrelor, the dura-
tion should be 7days pre-procedure.
• Aspirin therapy can be continued.
• Phosphodiesterase inhibitors such as dipyridamole should
be withheld at least 24 hours before a high-risk
procedure.
Emergency Pleural Procedures
Any bleeding risk should be corrected wherever it is prac­tical while in complex situations, input from haematologist may be required.
Coagulation prole evaluation is not mandatory, if there is no known history of coagulopathy and the patient is not on any anticoagulant medication [16].
37.2.2 Imaging
lung, the presence of emphysematous bullae or where sono­graphic views are not optimal, like posteriorly loculated pleural collections.

37.3 Thoracocentesis

Thoracocentesis can be performed for diagnostic (~50ml) or therapeutic (~500–1500ml) purposes depending on the indi­cation and amount of uid removed.
37.3.1 Indications
Pneumothorax
• Primary or secondary spontaneous pneumothorax
Pleural effusion
• Diagnostic tap
• Large volume aspiration to relieve patient’s symptoms, particularly shortness of breath
• For assessment of underlying non-expandable lung
37.3.2 Relative Contraindications
• Coagulopathy or concurrent anti-coagulation treatment
• Local infection at the site of puncture
• Pneumothorax
• No potential safe site for aspiration (e.g., Tethered lung, bullous disease mimicking pneumothorax, small volume pneumothorax)
• Mechanical ventilation which might increase the chances of tension pneumothorax or bronchopleural stula (chest drain preferred)
• Pleural effusions
• No safe site or route identied on USG (very small or posterior collections given the increased risk of neurovas­cular structures injury)
A recent radiological study (chest radiograph or USG) should be reviewed before starting the procedure to verify the indication and side of the pathology. Ultrasound guid­ance is recommended prior to pleural uid procedures except in emergent situations. Screening USG should be done in the position where the procedure is planned to be done. Ultrasound guidance is preferred as it increases yield and reduces complication risks due to its real-time capabilities. CT guidance may be helpful in some situations, particularly in cases of loculated pneumothorax/effusion with tethered
37.3.3 Size andType ofNeedle
Small bore needles are preferred to minimize the risks asso­ciated with diagnostic pleural aspiration (often needle 21G/40 mm is used). The depth of the uid in the pleural cavity should be assessed while planning the procedure to select optimum needle length. It also ensures the needle is not advanced too far, risking damage to deep structures. Commercially available kits for therapeutic pleural aspira­tion generally have larger 6F or 8Fr needles.
37 Nonvascular Thoracic Interventions
461
37.3.4 Technique
A slower and controlled drainage allows gradual re­expansion of the lung. This helps in early identication of signs and symptoms that might suggest the onset of re­expansion pulmonary oedema like worsening breathless­ness, hypoxia or chest tightness allowing the procedure to be stopped before life-threatening symptoms develop. The use of a three-way stopcock during aspiration allows drain­age to be stopped quickly if required. Monitoring pleural pressure and elastance with pleural uid manometry does not prevent pain or procedure-related complications com­pared to manometry-guided large volume therapeutic thoracentesis.
Therapeutic aspiration via syringe or gravity is advised. Vacuum drainage bottles or wall suction should be avoided in therapeutic thoracentesis as it is associated with high com­plication rate [7].
37.3.5 Volume ofDrainage
For a diagnostic pleural aspiration, 60ml aspirate is adequate for evaluation. Due to the risk of re-expansion pulmonary oedema, 1.5L is recommended as the upper limit in one sit­ting. However, if the patient develops respiratory distress before 1.5L is aspirated, the procedure is terminated. Larger volume drainage/aspiration may be done in certain circum­stances with close monitoring.
37.4.3 Drain Size
Surgical drainage generally uses larger bore tubes (up to 32–40 Fr), while image-guided drainage is done using cath­eters of smaller sizes typically. However, large bore cathe­ters, up to 32F (Thal-Quick, Cook Medical, United States), are now available. Seldinger drains of up to 14F bore are suitable for most indications. Serous effusions can be drained via 8F self-retaining catheters, exudative effusions require 10–16 F pigtail or Malecot’s catheter (Fig.37.1). Large-bore drains up to 32F are better suited for conditions, such as post-surgery, haemothorax and pneumothorax com­plicated by substantial air leak (as in trauma, secondary pneumothorax or ventilated patients). Spontaneous or iatro­genic pneumothorax and pleural infected pleural uid col­lections are managed with chest drains <14 F. However, larger-bore drains are the preferred rst choice by some operators for cases with secondary spontaneous pneumotho­rax who may have large air leaks. In patients with traumatic pneumothorax, 14F drains are shown to be as effective as 28F drains with no increased complications. Similarly, in cases of traumatic haemothorax in stable patients, small­bore drains have shown similar outcomes in comparison to large-bore drains. Chest drains inserted for the purpose of talc slurry pleurodesis should be at least 12 F as smaller drains can get blocked with talc particles. In patients with rib crowding, intercostal space should be measured to deter­mine the tube size to be used [7, 8].
37.4 Intercostal Drainage Catheter
Insertion
37.4.1 Indications
• Refractory pneumothorax
• Large benign or malignant pleural effusion drainage
• Symptomatic pleural effusions in mechanically ventilated
patients
• Pleurodesis
• Infected pleural collection
• Traumatic pneumothorax or haemothorax
• Post-surgical procedures like thoracoscopy, thoracic, or
cardiac surgeries
37.4.2 Contraindications
There are no absolute contraindications for pleural drain catheter placement, especially in emergencies.
Uncorrected coagulopathy is a relative contraindication.
37.4.4 Site ofCatheter Insertion
The midaxillary line in the fth or sixth intercostal space is the standard site for catheter insertion directed superior to inferior. However, the technique needs to be modied in cases of loculated effusions, depending on the site of locula­tion. Use of three-way stopcocks is encouraged to prevent air from being introduced into the pleural space during the pro­cedure. After satisfactory placement of catheter, it should be connected to an underwater seal drainage bag. USG and uo­roscopy can be used for guidance. CT is especially helpful in the case of rib crowding leading to poor visualization on USG and in the case of hydropneumothorax (Fig.37.2) [7].
37.4.5 Post-Insertion Care
Chest drains should be immediately clamped if there is repetitive coughing or the patient complains of chest pain. Post-procedure report should include details of the sutures used, distance at which the drain is xed and colour and con­sistency of uid drained. It should also provide instructions
462
abc
abcd
A. Jayant et al.
Fig. 37.1 USG-guided drainage of pleural uid using trocar tech­nique. (a) USG image showing pleural effusion (star). (b) USG images showing trocar and catheter being advanced into the pleural effusion
de
(arrows). (c) Final USG image after removal of trocar showing the pig­tail catheter in situ within the pleural effusion. (d) Pigtail catheter with trocar used for the procedure
f
Fig. 37.2 CT-guided drainage of hydropneumothorax. (a and b) Axial mediastinal and lung window CT images demonstrate right hydropneumothorax with air fluid level (arrows) and atelectasis of underlying right lung parenchyma (star). (c) CT image demon­strating puncture needle (arrow) in the right hydropneumothorax.
(d) CT image shows guidewire (arrow) being inserted into the pleural space through the puncture needle. (e and f) Axial (e) and coronal (f) maximum intensity projection CT images showing the pigtail catheter (arrows) inserted into the pleural space over the guidewire
37 Nonvascular Thoracic Interventions
463
for when to clamp/unclamp the drain, time and modality of follow-up imaging and whom to contact in case of complica­tions. A follow-up chest radiograph should be done after the insertion to ensure appropriate drain position. Appropriate analgesics and 6–8 hourly ushing with 30 ml saline (for small bore drains) are prescribed as needed.

37.5 Intrapleural Fibrinolytic Therapy

The primary indication for intrapleural brinolytic therapy (IFT) is empyema that is unlikely to resolve completely with tube thoracostomy alone due to loculations and brin depo­sition, resulting in non-expansion of the underlying lung. Various agents that can be used are streptokinase, urokinase, recombinant tissue plasminogen activator (rtPA) and DNase. The use of streptokinase and urokinase has not been shown to improve outcomes in terms of duration of hospital stay, surgical referral or death. A combination of rtPA and DNase has been reported to be more effective than any other combi­nation in terms of morbidity and reduction of surgical refer­ral. A dose of 10mg of tPA and 5 mg of DNase may be instilled twice daily with a gap of 2hours according to the MIST2 trial with a dwell time of 2hours should be allowed. A maximum duration of three days is recommended by the MIST2 trial [7].
• Whenever possible, it is recommended to use guards over the plastic dilators for Seldinger drains to prevent insert­ing an excessive length of the sharp-tipped dilators into the pleural cavity.
• All chest drains should be secured with sutures to prevent displacement.
• Chest drains should be immediately clamped if a patient complains of chest pain or repetitive coughing.
• A follow-up chest radiograph should be done and reviewed within a few hours of insertion to conrm the drain position.
• In cases of effusion, the volume of uid that can be safely drained over specic time periods should be stated in the post-procedure notes (e.g., 500ml/h).
• If an intercostal drain is not functioning and a new drain is needed, avoid using the old track when inserting the new one.

37.7 Indwelling Pleural Catheter Insertion

Indications Generally, an indwelling pleural catheter (IPC)
is considered for patients with malignant pleural effusion with a life expectancy of more than a few weeks, during which time the pleural effusion is likely to re-accumulate (Fig.37.3).
37.5.1 Catheter Removal
The removal should be done by a brisk pull followed by quickly occluding the wound using a swab. In cases of large­bore drains, it is advisable to take help of an assistant in tying the closing suture. A chest radiograph should be considered post removal.
In cases of pneumothorax, catheter can be removed with­out a “clamping trial” if there is full lung re-expansion and cessation of air leak.
The decision to remove a tube for infected pleural uid collection is based on several factors, including a reduction in the size of the pleural uid collection as seen on radio­logical imaging, clinical resolution of sepsis and fever, and minimal drainage output (less than 10 ml/day) for 48–72hours.

37.6 Practice Points

• Small-bore drains (less than 14 French) are appropriate in
most cases, including the drainage of empyema.
• Larger bore drains are recommended in cases of unstable
trauma patients, pneumothorax complicating mechanical
ventilation and if pleurodesis is intended.
• First line for recurrent malignant pleural effusion.
• Second line in cases of failed pleurodesis.
• In selected patients with recurrent non-malignant pleural effusions.
• Routine use of IPC in acute empyema is not recom­mended. It is useful in cases of empyema where surgical management has failed or was not possible due to patient’s comorbidities or poor performance status.
• In general, IPCs are not recommended in the treatment of simple pleural effusion. Their use may be considered when more than three aspiration events are required, and the patient is at high risk for developing complications of pleural interventions (coagulopathy).
• IPC is not a contraindication to chemotherapy.
37.7.1 Duration
There is no set limit on how long indwelling pleural catheters (IPCs) can remain in place, as they are intended to be a per­manent solution for recurrent pleural effusions. However, the risk of IPC-related pleural infection increases over time. The polyester cuff promotes granulation tissue formation and brosis, which helps anchor the drain in place, reducing the likelihood of catheter displacement and providing a barrier to infection.
464
r
ab
A. Jayant et al.
White "T" Plunger
Flexible Bottle
Foil Seal
Vacuum Bottle
Fig. 37.3 PleurX indwelling pleural catheter system for long-term pleural drainage. (a) PleurX drainage kit with the roller clamp, sheath, access needle, sheath, syringe and connector tubing. (b) Schematic diagram showing PleurX vacuum drainage bottle and its components
37.7.2 Drainage Frequency andDrainage Volume
antibiotics combined with surgical debridement. Minimally invasive endoscopic ultrasound-guided drainage can also be
Cap
Support Clip
Access Tip Cove
Access Tip
Roller ClampDrainage Line
done. It however requires long-term nasogastric intubation The typical initial drainage frequency is thrice weekly. However, recent literature indicates that daily drainage increases pleurode­sis rates and shortens the time to pleurodesis compared to alter­nate-day or symptom-guided drainage. Generally, around 500ml of pleural uid is drained, but up to 1500ml may be removed. In practice, smaller volumes are often drained, as tol­erated by patients, and drainage is stopped if the patient experi­ences chest discomfort or a persistent cough.
with the catheter being gradually withdrawn as the collec-
tion slowly resolves. There is scarcity of literature regarding
percutaneous drainage of mediastinal abscesses because of
limited space within the mediastinum and proximity of
major vascular structures, oesophagus and pulmonary
parenchyma. First evidence of percutaneous drainage of
mediastinal abscess was provided by Gobien etal. in 1984
[9]. Since then, percutaneous CT-guided drainage has been
proven to be associated with high technical and clinical suc-
cess rates [10].
37.7.3 Indications forIPC Removal
• Output of less than 50ml from the IPC on three consecu-
37.8.1 Procedure
tive occasions, no symptoms of uid re-accumulation and no signicant pleural effusion on imaging.
• Severe pain, non-resolving IPC-related skin/pleural infec-
Drainage can be performed by tandem trocar technique or
Seldinger technique.
tion, signicant device damage and irreversible IPC blockage with persistent uid formation.
• Pleural tumours like mesothelioma can inltrate along
37.8.2 Trocar Drainage
instrumentation sites, leading to catheter tract metastases, but do not usually require IPC removal.
A 20G needle is advanced into the collection under image
guidance. The inner stylet is withdrawn and a small amount
of uid is aspirated to ascertain satisfactory needle place-
37.8 Drainage ofMediastinal Collection
ment within collection. With the help of preliminary imaging
and the 20G needle, a self-retaining locking pigtail catheter Mediastinal abscess, although relatively rare, is a poten­tially life-threatening condition. Mortality rates can be as high as 40%. The traditional treatment has been intravenous
attached to a metal stiffener and trocar cannula is advanced
into the collection parallel and approximately 5mm adjacent
to 20G needle. The catheter advanced further into the collec-